Navigation Links
Launch of Novel Agents for the Treatment of Hepatitis C Virus Will Precipitate Treatment of At Least Half of 'Warehoused' Patients
Date:9/27/2010

BURLINGTON, Mass., Sept. 27 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the launch of novel therapies for the treatment of Hepatitis C Virus (HCV), including Vertex/Johnson & Johnson/Mitsubishi Tanabe's telaprevir and Merck's boceprevir, will precipitate several changes in HCV treatment. According to Patient Flow in Hepatitis C Virus, surveyed physicians plan to initiate treatment in at least half of their "warehoused" HCV1 patients one year after novel therapies become available. Patient "warehousing" is a term that has been coined to characterize the phenomenon of HCV patients opting out of treatment with current standard of care in anticipation of new therapies; psychiatric events, adverse events and liver health are top reasons keeping patients away from current therapies.

The report also finds that time from initial diagnosis to treatment initiation will decrease once novel HCV therapies are available. On average, surveyed physicians stated they wait 17 months to initiate treatment in HCV1 treatment-naive patients; this time will decrease to 7 months once novel treatment options are available.

"The arrival of telaprevir and boceprevir will alter more than the drug-treatment rate and treatment initiation timing in HCV," said Alexandra Makarova, M.D., Ph.D. "Physicians indicate they would increase the capacity of their HCV practice to accommodate the additional patients expected once novel therapies are available."

About Patient Flow in Hepatitis C VirusPatient Flow in Hepatitis C Virus is a 15-year, annualized patient forecast for each of the G7 countries that estimates the total size of the declining prevalent HCV population and segments it by viremic status, HCV genotype and line of therapy. It includes two components: an Excel workbook containing quantitative analysis, including patient forecast and modifiable assu
'/>"/>

SOURCE Decision Resources
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. New Smartphone App Launches for Cardiac Imaging Test
2. Effectively Educating the Marketplace to Support a Successful New Oncology Product Launch
3. Newly Re-launched Website Helps PhDs and MDs Capitalize on Growth in Life Science Industries
4. Elsevier Launches International Journal of Surgery Case Reports
5. Biomatrica Launches DNAgard® Blood and DNAstable Blood for Stabilization, Storage and Shipping of Whole Blood at Room Temperature
6. Pittsburgh Life Sciences Greenhouse Executive-in-Residence Launches Medical Device Company
7. Volcano Drives Innovation Forward With Three New U.S. Product Launches at TCT 2010
8. Roche Launches New Initiative - Roche Goes to Town
9. Medical Cannabis University™ Launches, Puts Thousands Back to Work to Help Veterans and the Chronically Ill
10. Olympus Launches 2011 National Innovation Awards Program
11. Access Pharmaceuticals Launches MuGard Product Website
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... -- Smile Train and its technology partner BioDigital have been ... among leading global health innovations in The Hive at ... Washington, D.C. at The John F. Kennedy ... Train is honored to be represented through our partnership ... health and medicine that TEDMED unites each year," said ...
(Date:7/25/2014)... -- CVS Caremark Corporation (NYSE: CVS ) will ... 2014, at 8:30 a.m. (EDT) with analysts and investors ... An audio webcast of the conference call will ... the CVS Caremark website for all interested parties.  To ... will be archived and available on the web site ...
(Date:7/25/2014)... Cardinal Health will today name three of the nation,s ... Independent Pharmacy Best Practices Competition, during the company,s ... gatherings of independent pharmacists. The Best ... Ohio , Tennessee and ... implementing exceptionally creative methods that demonstrate how independent pharmacies ...
Breaking Medicine Technology:Smile Train and BioDigital Selected to Showcase Virtual Surgery Simulator in The Hive at TEDMED 2014 2Smile Train and BioDigital Selected to Showcase Virtual Surgery Simulator in The Hive at TEDMED 2014 3Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 2Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 3Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 4Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 5Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 6
... 1, 2012  Ultragenyx Pharmaceutical Inc., a biotechnology company ... genetic disorders, today announced results from a first-in-human, ... with hereditary inclusion body myopathy (HIBM) showing that ... profile on absorption after oral administration.  UX001 is ...
... (OTC Bulletin Board: NWBO ) (NW Bio) today announced ... received approval of a major grant from the Sachsische Aufbau ... will reimburse fifty percent (50%) of the costs for manufacturing ... for brain cancer at up to ...
Cached Medicine Technology:Ultragenyx Announces Phase 1 Results of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Neuromuscular Disease 2Ultragenyx Announces Phase 1 Results of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Neuromuscular Disease 3Northwest Bio Awarded $5.5 Million German Government Grant 2Northwest Bio Awarded $5.5 Million German Government Grant 3Northwest Bio Awarded $5.5 Million German Government Grant 4
(Date:7/26/2014)... York (PRWEB) July 26, 2014 The ... in state and federal litigations since the 2012 recall ... surpassed 3,700 filings, Bernstein Liebhard LLP reports. According to ... least 2,064 cases have been filed in the New ... Hip Stem and the ABG II Modular Hip Stem ...
(Date:7/26/2014)... 2014 As reported by Lauren ... based on 3 factors: smaller spaces, multi-generational access, and ... trend of 2014 lists, including this article on ... Amerec , a leading manufacturer of steam bath generators, ... due to smaller spaces and an effort to reduce ...
(Date:7/26/2014)... According to the Tinnitus ... this is a comprehensive guide that consists ... all types of disorders related to ... due to Ménière's disease ,     Objective ... tinnitus ,     Inner, middle or external ...
(Date:7/26/2014)... Dallas, TX (PRWEB) July 26, 2014 ... sclerosis or encephalomyelitis disseminata, is an inflammatory disease ... in the brain and spinal cord are damaged. ... the nervous system to communicate, resulting in a ... mental, and sometimes psychiatric problems. Multiple sclerosis takes ...
(Date:7/26/2014)... (PRWEB) July 26, 2014 Another DePuy Pinnacle ... Orthopedics, Inc., has been filed by Wright & Schulte LLC. ... on behalf of an Erie County, Ohio man who ... left hip and groin since receiving his Pinnacle Hip implant ... man will be forced to undergo a complex and risky ...
Breaking Medicine News(10 mins):Health News:Stryker Hip Lawsuit Filings in State and Federal Litigations Continue to Rise, Bernstein Liebhard LLP Reports 2Health News:Stryker Hip Lawsuit Filings in State and Federal Litigations Continue to Rise, Bernstein Liebhard LLP Reports 3Health News:Amerec Finds Bathroom Design Trends Change Based on Water Consumption and Other Factors 2Health News:Tinnitus Miracle Book Review Exposes Thomas Coleman's Guide for Treating Tinnitus – Vkool.com 2Health News:Multiple Sclerosis Therapeutics Clinical Trials Market Review H2 2014 Analysis Report Available at MarketOptimizer.org 2Health News:Multiple Sclerosis Therapeutics Clinical Trials Market Review H2 2014 Analysis Report Available at MarketOptimizer.org 3Health News:Multiple Sclerosis Therapeutics Clinical Trials Market Review H2 2014 Analysis Report Available at MarketOptimizer.org 4Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Recipient Who Faces Surgery To Replace Artificial Hip Implant 2Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Recipient Who Faces Surgery To Replace Artificial Hip Implant 3Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Recipient Who Faces Surgery To Replace Artificial Hip Implant 4Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Recipient Who Faces Surgery To Replace Artificial Hip Implant 5
... archeologists claim to have excavated fresh evidence supporting the view ... of researchers led by Georgi Nehrizov claim to have unearthed ... period which was 4000 years ago. The skull was found ... of Svilengrad in Bulgaria. ,Georgi Nehrizov informed the ...
... at all Public Offices across Bangkok the capital city ... disclosed a senior official from the Bangkok Metropolitan Administration. ... the Thai News Agency that the initial reforms have ... the BMA’s headquarters where smoking has already been prohibited ...
... London: Surgical Vasectomy is in the midst of competition from ... potential of giving the procedure// a run for its money!, ... Device’ or IVD that can be inserted through a tiny ... strength from a tiny plug of silicone gel which stops ...
... people with psoriasis are at higher risk for heart ... scaly patches on the skin//. ,The study ... that the association between psoriasis and heart attack appeared ... there is an increase in the levels of C-reactive ...
... 10th of October is observed as World Health Day globally. ... 1992 as an annual activity of the World Federation// for ... Ever since then the Federation has selected a theme each ... the theme globally. ,The theme highlighted this ...
... Ministers of chikungunya-affected States will be oganised by the Union ... ,The agenda is to come out with a ... 1.3 million people in India. Chikungunya has taken several lives, ... chair the meeting of the Health Ministers of the four ...
Cached Medicine News:Health News:Psoriasis raises risk for heart attack 2Health News:Impact of Mental Illness on Suicide 2
PS2A200 Power supply is a high current power supply ideal for all types of electrophoresis blotting and short electrophoresis runs....
EPS 3501 : 3500 V, 150 mA, 100 W maximum. Constant voltage, constant current, or constant power modes. Stores and recalls three protocols. Excellent for manual DNA sequencing and IEF applications....
... C.B.S.SCIENTIFIC offers four different Series II ... the EPS-4000-II, and the EPS-6000-II. These ... constant current, and constant power operating ... powerful 300 milliamps maximum current/300 watts ...
... The PowerPac Basic power supply, ... output of 10-300 V, 4-400 ... unit contains a built-in switch ... with the appropriate power cord. ...
Medicine Products: